Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
NHS England accused of interference over hepatitis C drug

Officials at NHS England have been accused of interfering in a process to decide whether a drug which can cure Hepatitis C should be made available to patients on the health service.

Published
26 May 2015
From
Channel 4 News
Hepatitis C treatment for people in prison may be highly cost-effective in England

Reducing the duration of direct-acting antiviral treatment for hepatitis C will make treatment for people in prison in England highly cost-effective, and could provide an important opportunity

Published
21 May 2015
By
Keith Alcorn
Hepatitis B and C - An Action Plan for Saving Lives in Europe

Last year, leading experts, institutions, patient organisations and pharmaceutical industry representatives met and agreed that the major recommendations produced between 2011 and 2014 should be compiled into one comprehensive document, to make it easier for policy makers, decision makers, civil society organisations and healthcare institutions to tackle viral hepatitis effectively.

Published
20 May 2015
From
European Liver Patients Association
HIV Outbreak: Why Austin? Why Indiana?

I think the reason we see it here is because we found it. Many areas of the country are experiencing, along with drug abuse, especially in smaller, rural towns, high unemployment, lower incomes and a lack of education. Sadly, there are places in this country where the future looks bleak

Published
20 May 2015
From
WHAS 11.com
Pricing remains main barrier to HCV eradication

Eradication is technically feasible, Dr. Edlin said during a Monday morning AASLD Clinical Symposium, but not likely until current pricing policies change.

Published
20 May 2015
From
Digestive Disease Week News
Achillion partners with J&J to develop hepatitis C drugs

Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time.

Published
20 May 2015
From
Reuters
Is Gilead Sciences Its Own Worst Enemy?

Gilead's science is so good that it's actually destroying the company's business. Pharma companies, like most other businesses, make the bulk of their money through repeat business. Gilead, however, is doing something really no other drugmaker is doing -- namely curing patients of devastating infectious diseases.

Published
20 May 2015
From
Motley Fool
Statin use associated with lower risk of liver decompensation and death in hepatitis C patients with cirrhosis

People with hepatitis and liver cirrhosis were significantly less likely to progress to decompensated disease and less likely to die if they used statins to control blood

Published
19 May 2015
By
Liz Highleyman
If I'm Cured of Hepatitis C, When Is It Safe to Drink Again?

Doctors say the answer lies in whether a patient is honest about their alcohol use and how much damage the liver sustained before treatment.

Published
19 May 2015
From
Healthline
Investing in hepatitis C drugs could save the economy billions, researchers suggest

Researchers who examined the effect of treating hepatitis C patients with the newer generation of oral drugs suggest while these medications may cost tens of thousands of dollars for a 12-week course, they could avert billions in lost productivity.

Published
19 May 2015
From
Medical News Today
← First12345...167Next →

Filter by country